Robert B. Geller

1.7k total citations
48 papers, 1.3k citations indexed

About

Robert B. Geller is a scholar working on Hematology, Oncology and Surgery. According to data from OpenAlex, Robert B. Geller has authored 48 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Hematology, 20 papers in Oncology and 12 papers in Surgery. Recurrent topics in Robert B. Geller's work include Acute Myeloid Leukemia Research (17 papers), Hematopoietic Stem Cell Transplantation (13 papers) and Neutropenia and Cancer Infections (10 papers). Robert B. Geller is often cited by papers focused on Acute Myeloid Leukemia Research (17 papers), Hematopoietic Stem Cell Transplantation (13 papers) and Neutropenia and Cancer Infections (10 papers). Robert B. Geller collaborates with scholars based in United States, United Kingdom and Germany. Robert B. Geller's co-authors include John R. Wingard, S M Devine, H. Kent Holland, Richard E. Mullins, Rein Saral, Craig A. Hurwitz, Marianna Zahurak, C D Hillyer, Curt I. Civin and J. E. Karp and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Robert B. Geller

47 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert B. Geller United States 20 771 364 232 193 168 48 1.3k
J Gmür Switzerland 20 1.3k 1.7× 366 1.0× 180 0.8× 212 1.1× 218 1.3× 51 1.7k
Xiao Ma China 17 867 1.1× 366 1.0× 336 1.4× 243 1.3× 393 2.3× 95 1.4k
Yahya Büyükaşık Türkiye 20 818 1.1× 334 0.9× 113 0.5× 246 1.3× 191 1.1× 164 1.6k
Seth A. Rudnick United States 15 664 0.9× 302 0.8× 197 0.8× 132 0.7× 113 0.7× 23 1.3k
William E. Beschorner United States 9 662 0.9× 170 0.5× 153 0.7× 102 0.5× 126 0.8× 11 1.1k
Atsuo Maruta Japan 19 1.0k 1.3× 254 0.7× 554 2.4× 217 1.1× 107 0.6× 67 1.5k
Ulas D. Bayraktar United States 18 407 0.5× 282 0.8× 125 0.5× 139 0.7× 116 0.7× 44 1.1k
Brett Glotzbecker United States 18 753 1.0× 484 1.3× 178 0.8× 170 0.9× 478 2.8× 53 1.3k
Aleksandar Radujkovic Germany 18 471 0.6× 191 0.5× 96 0.4× 186 1.0× 244 1.5× 53 1.3k
Étienne Lengliné France 17 417 0.5× 416 1.1× 223 1.0× 136 0.7× 109 0.6× 59 1.2k

Countries citing papers authored by Robert B. Geller

Since Specialization
Citations

This map shows the geographic impact of Robert B. Geller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert B. Geller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert B. Geller more than expected).

Fields of papers citing papers by Robert B. Geller

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert B. Geller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert B. Geller. The network helps show where Robert B. Geller may publish in the future.

Co-authorship network of co-authors of Robert B. Geller

This figure shows the co-authorship network connecting the top 25 collaborators of Robert B. Geller. A scholar is included among the top collaborators of Robert B. Geller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert B. Geller. Robert B. Geller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Schubert, Jörg, Peter Hillmen, Alexander Röth, et al.. (2008). Eculizumab, a terminal complement inhibitor, improves anaemia in patients with paroxysmal nocturnal haemoglobinuria. British Journal of Haematology. 142(2). 263–272. 40 indexed citations
4.
Lazarus, Hillard M., Waleska S. Pérez, John P. Klein, et al.. (2006). Autotransplantation versus HLA‐matched unrelated donor transplantation for acute myeloid leukaemia: a retrospective analysis from the Center for International Blood and Marrow Transplant Research. British Journal of Haematology. 132(6). 755–769. 41 indexed citations
5.
6.
Geller, Robert B., et al.. (1999). Oral Chemotherapy Agents in the Treatment of Leukaemia. Drugs. 58(Supplement 3). 109–118. 5 indexed citations
7.
Geller, Robert B. & Robert A. Bray. (1997). CD34 expression on acute myelocytic leukemia cells. Leukemia Research. 21(5). 387–389. 3 indexed citations
8.
9.
Vogler, William R., Wolfgang E. Berdel, Robert B. Geller, et al.. (1996). A Phase II Trial of Autologous Bone Marrow Transplantation (ABMT) in Acute Leukemia with Edelfosine Purged Bone Marrow. Advances in experimental medicine and biology. 416. 389–396. 26 indexed citations
10.
Geller, Robert B.. (1996). Use of cytokines in the treatment of acute myelocytic leukemia: a critical review.. Journal of Clinical Oncology. 14(4). 1371–1382. 44 indexed citations
11.
Schultz, Alyssa B., Robert B. Geller, & C D Hillyer. (1995). The Role of Bone Marrow Transplantation in the Treatment of Myelodysplastic Syndromes. Journal of Hematotherapy. 4(4). 323–334. 2 indexed citations
12.
Geller, Robert B., et al.. (1995). Randomized trial of loperamide versus dose escalation of octreotide acetate for chemotherapy‐induced diarrhea in bone marrow transplant and leukemia patients. American Journal of Hematology. 50(3). 167–172. 19 indexed citations
13.
Larson, Richard A., Robert B. Geller, Linda Janisch, et al.. (1995). Encephalopathy is the dose-limiting toxicity of intravenous hepsulfam: results of a phase I trial in patients with advanced hematological malignancies. Cancer Chemotherapy and Pharmacology. 36(3). 204–210. 1 indexed citations
14.
Harris, Alan G., Thomas M. O’Dorisio, Eugene A. Woltering, et al.. (1995). Consensus statement: Octreotide dose titration in secretory diarrhea. Digestive Diseases and Sciences. 40(7). 1464–1473. 45 indexed citations
15.
16.
Myers, S, Steven M. Devine, Kathleen O’Toole, et al.. (1992). A Pilot Study of Prophylactic Aerosolized Amphotericin B In Patients at Risk for Prolonged Neutropenia. Leukemia & lymphoma. 8(3). 229–233. 42 indexed citations
17.
Geller, Robert B. & Richard A. Larson. (1991). Therapy for acute myeloid leukemia and acute lymphoblastic leukemia in adults. Current Opinion in Oncology. 3(1). 30–38. 5 indexed citations
18.
Geller, Robert B., Marianna Zahurak, Craig A. Hurwitz, et al.. (1990). Prognostic importance of immunophenotyping in adults with acute myelocytic leukaemia: the significance of the stem‐cell glycoprotein CD34 (My 10). British Journal of Haematology. 76(3). 340–347. 151 indexed citations
19.
20.
Geller, Robert B., Georgia B. Vogelsang, John R. Wingard, et al.. (1988). Successful marrow transplantation for acute myelocytic leukemia following therapy for Hodgkin's disease.. Journal of Clinical Oncology. 6(10). 1558–1561. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J Gmür Breakdown of academic impact, for papers by Xiao Ma Breakdown of academic impact, for papers by Yahya Büyükaşık Breakdown of academic impact, for papers by Seth A. Rudnick Breakdown of academic impact, for papers by William E. Beschorner Breakdown of academic impact, for papers by Atsuo Maruta Breakdown of academic impact, for papers by Ulas D. Bayraktar Breakdown of academic impact, for papers by Brett Glotzbecker Breakdown of academic impact, for papers by Aleksandar Radujkovic Breakdown of academic impact, for papers by Étienne Lengliné
Rankless by CCL
2026